Nuvation Bio Inc. (NUVB)
NYSE: NUVB · Real-Time Price · USD
5.69
-0.12 (-1.98%)
Sep 16, 2026, 1:15 PM EDT - Market open
Nuvation Bio Stock Forecast
Stock Price Forecast
According to 11 analysts polled by S&P Global, Nuvation Bio stock has a consensus rating of "Strong Buy" and an average price target of $13.1. The average 1-year stock price forecast is 130.43% higher than the current stock price, while the lowest is $7.00 (+23.13%) and the highest is $21 (+269.39%).
Price Target: $13.1 (+130.43%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Nuvation Bio stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 7 | 7 | 7 | 7 |
| Buy | 2 | 2 | 2 | 2 | 2 | 3 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 10 | 10 | 10 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wedbush | Wedbush | Buy Maintains $11 | Buy | Maintains | $11 | +93.49% | Sep 15, 2026 |
| Truist Financial | Truist Financial | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Sep 15, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Sep 15, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $12 | Buy | Initiates | $12 | +111.08% | Aug 21, 2026 |
| B. Riley Securities | B. Riley Securities | Buy Maintains $12 → $14 | Buy | Maintains | $12 → $14 | +146.26% | Aug 7, 2026 |
Financial Forecast
Revenue This Year
199.12M
from 62.90M
Increased by 216.56%
Revenue Next Year
282.43M
from 199.12M
Increased by 41.83%
EPS This Year
-0.29
from -0.49
EPS Next Year
-0.02
from -0.29
EPS and Forward PE are based on non-GAAP adjusted numbers.